Hologic Inc. Share Price Today: Live Updates & Key Insights

Hologic Inc. share price today is $75.42, up 0.11%. The stock opened at $75.4025 against the previous close of $75.33, with an intraday high of $75.545 and low of $75.37.

Hologic Inc. Share Price Chart

Hologic Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Hologic Inc. Share Price Performance

$75.42 0.0011(0.11%) HOLX at 23 Mar 2026 01:29 PM Medical Instruments & Supplies
Lowest Today 75.37
Highest Today 75.545
Today’s Open 75.4025
Prev. Close 75.33
52 Week High 75.75
52 Week Low 51.90
Day’s Range: Low 75.37 High 75.545
52-Week Range: Low 51.90 High 75.75
1 day return -
1 Week return +0.33
1 month return -0.03
3 month return +0.65
6 month return +12.05
1 year return +21.89
3 year return -4.11
5 year return +1.95
10 year return -

Hologic Inc. Institutional Holdings

Vanguard High-Yield Corporate Inv 14.01

Vanguard Group Inc 11.69

T. Rowe Price Investment Management,Inc. 9.65

BlackRock Inc 8.70

State Street Corp 4.47

Manufacturers Life Insurance Co 4.23

Amvescap Plc. 3.18

Vanguard Total Stock Mkt Idx Inv 3.14

Geode Capital Management, LLC 2.65

Vanguard 500 Index Investor 2.54

Victory Capital Management Inc. 2.51

Fidelity International Ltd 2.34

Vanguard Small Cap Index 2.26

Vanguard Short-Term Investment-Grade Inv 1.95

Pentwater Capital Management LP 1.90

Victory Sycamore Established Value R 1.80

Morgan Stanley - Brokerage Accounts 1.75

NORGES BANK 1.71

Millennium Management LLC 1.57

Vanguard Small Cap Value Index Inv 1.45

Vanguard Interm-Term Invmt-Grade Inv 1.38

Arrowstreet Capital Limited Partnership 1.35

Bank of America Corp 1.31

iShares Core S&P 500 ETF 1.27

Fidelity 500 Index 1.27

Northern Trust Corp 1.25

T. Rowe Price US Mid-Cap Growth Equity 1.25

Fidelity Canadian Large Cap Sr B 1.19

State Street® SPDR® S&P 500® ETF 1.17

JHancock Fundamental Large Cap Core A 1.15

Manulife IM US Large Cap Core 1.14

CI Global Leaders Fund D 1.10

UBS Group AG 1.10

Invesco S&P 500® Equal Weight ETF 1.02

Dimensional Fund Advisors, Inc. 1.01

JPMorgan Chase & Co 0.99

Qube Research & Technologies 0.95

Vanguard STAR Core-Plus Bond Instl 0.92

BlackRock Event Driven Equity Instl 0.79

State Street®HlthCrSelSectSPDR®ETF 0.74

Hologic Inc. Market Status

Strong Buy: 3

Buy: 3

Hold: 14

Sell: 0

Strong Sell: 0

Hologic Inc. Fundamentals

Market Cap 16834.90 M

PB Ratio 3.1192

PE Ratio 31.2905

Enterprise Value 16990.50 M

Total Assets 9014.90 M

Volume 4231759

Hologic Inc. Company Financials

Annual Revenue FY25:4100500000 4100.5M, FY24:4030300000 4030.3M, FY23:4030400000 4030.4M, FY22:4862800000 4862.8M, FY21:5632300000 5632.3M

Annual Profit FY25:2501100000 2501.1M, FY24:2227800000 2227.8M, FY23:2071500000 2071.5M, FY22:2997400000 2997.4M, FY21:3795800000 3795.8M

Annual Net worth FY25:565700000 565.7M, FY24:789500000 789.5M, FY23:456000000 456.0M, FY22:1302000000 1302.0M, FY21:1871500000 1871.5M

Quarterly Revenue Q4/2025:1047800000 1047.8M, Q3/2025:1049500000 1049.5M, Q2/2025:1023800000 1023.8M, Q1/2025:1005300000 1005.3M, Q4/2024:1021800000 1021.8M

Quarterly Profit Q4/2025:586400000 586.4M, Q3/2025:639100000 639.1M, Q2/2025:576600000 576.6M, Q1/2025:377300000 377.3M, Q4/2024:580500000 580.5M

Quarterly Net worth Q4/2025:179100000 179.1M, Q3/2025:187300000 187.3M, Q2/2025:194900000 194.9M, Q1/2025:-17400000 -17.4M, Q4/2024:201000000 201.0M

About Hologic Inc. & investment objective

Company Information Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Organisation Medical Instruments & Supplies

Employees 7070

Industry Medical Instruments & Supplies

CEO Mr. Stephen P. MacMillan

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Hologic Inc. FAQs

What is the share price of Hologic Inc. today?

The current share price of Hologic Inc. is $75.42.

Can I buy Hologic Inc. shares in India?

Yes, Indian investors can buy Hologic Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Hologic Inc. shares in India?

You can easily invest in Hologic Inc. shares from India by:

Can I buy fractional shares of Hologic Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Hologic Inc.?

Hologic Inc. has a market cap of $16834.90 M.

In which sector does Hologic Inc. belong?

Hologic Inc. operates in the Medical Instruments & Supplies sector.

What documents are required to invest in Hologic Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Hologic Inc.?

The PE ratio of Hologic Inc. is 31.29 and the PB ratio is 3.12.